Page 8 - Protein Sciences News Today

American Capital Management Inc. grew its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 353.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 866,600 shares of the biotechnology company’s stock after purchasing an additional 675,354 shares during the quarter. Bio-Techne […]

Aristotle Atlantic Partners LLC raised its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 305.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 523,203 shares of the biotechnology company’s stock after acquiring an additional 394,118 shares during the period. Bio-Techne makes up […]

Campbell & CO Investment Adviser LLC grew its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 125.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 11,180 shares of the biotechnology company’s stock after acquiring an additional 6,224 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Bio-Techne were worth […]

The Manufacturers Life Insurance Company boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 305.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 145,964 shares of the biotechnology company’s stock after buying an additional 110,002 shares during the period. The […]

The Manufacturers Life Insurance Company increased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 305.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 145,964 shares of the biotechnology company’s stock after acquiring an additional 110,002 shares during the period. The Manufacturers Life […]

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 362.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,533 shares of the biotechnology company’s stock after acquiring an additional […]

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been given a consensus rating of “Moderate Buy” by the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month […]

Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Risk & Volatility Bio-Techne has a beta of 1.26, meaning that its […]

Quadrant Capital Group LLC grew its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 267.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,556 shares of the biotechnology company’s stock after purchasing an additional 1,132 shares during the quarter. Quadrant Capital […]

Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility Bio-Techne has a beta of 1.25, suggesting that its […]